| (Values in U.S. Thousands) | Mar, 2025 | Sep, 2024 | Jun, 2024 | Mar, 2024 | Sep, 2023 |
| Sales | 12,500 | 13,335 | 13,883 | 14,750 | 12,063 |
| Sales Growth | -6.26% | -3.95% | -5.88% | +22.27% | +12.76% |
| Net Income | 175 | -1,011 | -922 | -3,029 | -6,020 |
| Net Income Growth | +117.31% | -9.65% | +69.56% | +49.68% | -83.03% |
IM Cannabis Corp (IMCC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Fiscal Year End Date: 12/31